bluebird bio (BLUE)
(Delayed Data from NSDQ)
$0.49 USD
0.00 (-0.61%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $0.49 0.00 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO8/14/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | NA |
ABR | 2.73 |
Earnings ESP
|
26.47% |
---|---|
Current Year | -1.62 |
Next Year | -0.88 |
EPS (TTM) | -2.47 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.09M | 18.19M | 101.13M | 255.51M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 16.10M | 27.30M | 131.37M | 310.90M |
Low Estimate | 16.06M | 12.68M | 70.26M | 189.80M |
Year ago Sales | 6.89M | 12.39M | 29.50M | 101.13M |
Year over Year Growth Est. | 133.47% | 46.84% | 242.86% | 152.65% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.43 | -1.62 | -0.88 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.35 | -0.34 | -1.31 | -0.46 |
High Estimate | -0.35 | -0.34 | -1.23 | -0.46 |
Low Estimate | -0.63 | -0.56 | -2.29 | -1.18 |
Year ago EPS | -0.67 | -0.66 | -1.93 | -1.62 |
Year over Year Growth Est. | 28.36% | 34.85% | 16.06% | 45.93% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 1 | 3 | 5 |
Down Last 7 Days | 1 | 1 | 1 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 2 | 2 | 3 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.43 | -1.62 | -0.88 |
7 Days Ago | -0.47 | -0.41 | -1.66 | -0.96 |
30 Days Ago | -0.47 | -0.41 | -1.66 | -0.96 |
60 Days Ago | -0.43 | -0.39 | -1.68 | -1.15 |
90 Days Ago | -0.49 | -0.44 | -1.76 | -1.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.34 | -1.31 | -0.46 |
Zacks Consensus Estimate | -0.48 | -0.43 | -1.62 | -0.88 |
Earnings ESP | 26.47% | 20.56% | 19.44% | 47.49% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.78 | -0.66 | -0.67 | NA |
Estimate | NA | NA | -0.69 | -0.72 | NA |
Difference | NA | NA | 0.03 | 0.05 | 0.04 |
Surprise | NA | NA | 4.35% | 6.94% | 5.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more